Back to: products

Europe Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service

PrintEmail
Apr 2023 - 186 Pages - From $3,200
(Excel Data Sheet: $1,500)
Description

The report cover may be different from the image shown.

Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

Europe clinical trials market was valued at valued at $10,939.1 million in 2022 and will grow by 6.4% annually over 2022-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.
Highlighted with 99 tables and 79 figures, this 186-page report “Europe Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2031 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Country.

Based on Product Category, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Trials of Drugs
o Small Molecule Drugs
o Vaccines
o Cell & Gene Therapy
o Other Drugs
• Trials of Devices
• Trials of Procedures

Based on Phase, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Phase I
• Phase II
• Phase III
• Phase IV

By Design, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Interventional Studies
o Randomized Control Trial
o Adaptive Clinical Trial
o Non-randomized Control Trial
• Observational Studies
o Cohort Study
o Case Control Study
o Cross Sectional Study
o Ecological Study
• Expanded Access Trials

By Service Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Protocol Designing
• Site Identification
• Patient Recruitment
• Laboratory Services
• Bioanalytical Testing Services
• Clinical Trial Data Management Services
• Clinical Trial Supply & Logistic Services
• Decentralized Clinical Trial Services
• Medical Device Testing Services
• Other Clinical Trial Services

By Indication, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Oncology
• Infectious Diseases
• Cardiology
• Obesity
• Diabetes
• Neurology
• Immunology
• Pain Management
• Other Indications

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Pharmaceutical and Biotechnological Companies
• Clinical Research Organizations
• Clinical Testing Laboratories
• Other End Users

Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of each national market by Phase, Design, and Indication over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Accell Clinical Research LLC
Charles River Laboratories
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America (Covance Inc.)
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
PhlexEurope
PRA Health Sciences
Sanofi SA
SGS SA (SGS Life Sciences)
Syneos Health Inc.
Wuxi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the Market 27
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 29
2.2 Major Growth Drivers 33
2.3 Market Restraints and Challenges 40
2.4 Emerging Opportunities and Market Trends 43
2.5 Porter’s Fiver Forces Analysis 47
3 Segmentation of Europe Market by Product Category 51
3.1 Market Overview by Product Category 51
3.2 Trials of Drugs 53
3.2.1 Small Molecule Drugs 54
3.2.2 Vaccines 55
3.2.3 Cell & Gene Therapy 56
3.2.4 Other Drugs 57
3.3 Trials of Devices 58
3.4 Trials of Procedures 59
4 Segmentation of Europe Market by Phase 60
4.1 Market Overview by Phase 60
4.2 Phase I 62
4.3 Phase II 63
4.4 Phase III 64
4.5 Phase IV 65
5 Segmentation of Europe Market by Design 66
5.1 Market Overview by Design 66
5.2 Interventional Studies 68
5.2.1 Randomized Control Trial 70
5.2.2 Adaptive Clinical Trial 71
5.2.3 Non-randomized Control Trial 72
5.3 Observational Studies 73
5.3.1 Cohort Study 75
5.3.2 Case Control Study 76
5.3.3 Cross Sectional Study 77
5.3.4 Ecological Study 78
5.4 Expanded Access Trials 79
6 Segmentation of Europe Market by Service Type 80
6.1 Market Overview by Service Type 80
6.2 Protocol Designing 82
6.3 Site Identification 83
6.4 Patient Recruitment 84
6.5 Laboratory Services 85
6.6 Bioanalytical Testing Services 86
6.7 Clinical Trial Data Management Services 87
6.8 Clinical Trial Supply & Logistic Services 88
6.9 Decentralized Clinical Trial Services 89
6.10 Medical Device Testing Services 90
6.11 Other Clinical Trial Services 91
7 Segmentation of Europe Market by Indication 92
7.1 Market Overview by Indication 92
7.2 Oncology 94
7.3 Infectious Diseases 95
7.4 Cardiology 96
7.5 Obesity 97
7.6 Diabetes 98
7.7 Neurology 99
7.8 Immunology 100
7.9 Pain Management 101
7.10 Other Indications 102
8 Segmentation of Europe Market by End User 103
8.1 Market Overview by End User 103
8.2 Pharmaceutical and Biotechnological Companies 105
8.3 Clinical Research Organizations 106
8.4 Clinical Testing Laboratories 107
8.5 Other End Users 108
9 European Market 2021-2031 by Country 109
9.1 Overview of European Market 109
9.2 Germany 112
9.3 U.K. 114
9.4 France 116
9.5 Spain 118
9.6 Italy 120
9.7 Russia 122
9.8 Rest of European Market 124
10 Competitive Landscape 126
10.1 Overview of Key Vendors 126
10.2 New Product Launch, Partnership, Investment, and M&A 130
10.3 Company Profiles 131
Accell Clinical Research LLC 131
Charles River Laboratories 133
ClinDatrix Inc 136
Clinipace 137
Eli Lilly and Company 139
F. Hoffmann-La Roche Ltd. 142
ICON PLC 145
IQVIA Holdings, Inc. 148
Laboratory Corporation of America (Covance Inc.) 152
Novo Nordisk AS 156
PAREXEL International Corporation 159
Pfizer Inc. 163
Pharmaceutical Product Development LLC 168
Phlexglobal 171
PRA Health Sciences 173
Sanofi SA 175
SGS SA (SGS Life Sciences) 178
Syneos Health Inc. 181
Wuxi AppTec Inc. 184
RELATED REPORTS 186

List of Tables:

Table 1. Snapshot of Europe Clinical Trials Market in Balanced Perspective, 2022-2031 20
Table 2. Total Number of Registered Clinical Studies Worldwide, 2010-2021 23
Table 3. World Economic Outlook, 2021-2031 25
Table 4. World Economic Outlook, 2021-2023 26
Table 5. Scenarios for Economic Impact of Ukraine Crisis 30
Table 6. World Health Spending by Region, $ bn, 2013-2020 39
Table 7. Main Product Trends and Market Opportunities in Europe Clinical Trials Market 43
Table 8. Europe Clinical Trials Market by Product Category, 2021-2031, $ mn 51
Table 9. Europe Clinical Trials Market: Trials of Drugs by Drug Type, 2021-2031, $ mn 53
Table 10. Europe Clinical Trials Market by Phase, 2021-2031, $ mn 60
Table 11. Europe Clinical Trials Market by Design, 2021-2031, $ mn 66
Table 12. Europe Clinical Trials Market: Interventional Studies by Segment, 2021-2031, $ mn 69
Table 13. Europe Clinical Trials Market: Observational Studies by Segment, 2021-2031, $ mn 74
Table 14. Europe Clinical Trials Market by Service Type, 2021-2031, $ mn 80
Table 15. Europe Clinical Trials Market by Indication, 2021-2031, $ mn 92
Table 16. Europe Clinical Trials Market by End User, 2021-2031, $ mn 103
Table 17. Europe Clinical Trials Market by Country, 2021-2031, $ mn 111
Table 18. Germany Clinical Trials Market by Phase, 2021-2031, $ mn 113
Table 19. Germany Clinical Trials Market by Design, 2021-2031, $ mn 113
Table 20. Germany Clinical Trials Market by Indication, 2021-2031, $ mn 113
Table 21. U.K. Clinical Trials Market by Phase, 2021-2031, $ mn 115
Table 22. U.K. Clinical Trials Market by Design, 2021-2031, $ mn 115
Table 23. U.K. Clinical Trials Market by Indication, 2021-2031, $ mn 115
Table 24. France Clinical Trials Market by Phase, 2021-2031, $ mn 117
Table 25. France Clinical Trials Market by Design, 2021-2031, $ mn 117
Table 26. France Clinical Trials Market by Indication, 2021-2031, $ mn 117
Table 27. Spain Clinical Trials Market by Phase, 2021-2031, $ mn 119
Table 28. Spain Clinical Trials Market by Design, 2021-2031, $ mn 119
Table 29. Spain Clinical Trials Market by Indication, 2021-2031, $ mn 119
Table 30. Italy Clinical Trials Market by Phase, 2021-2031, $ mn 121
Table 31. Italy Clinical Trials Market by Design, 2021-2031, $ mn 121
Table 32. Italy Clinical Trials Market by Indication, 2021-2031, $ mn 121
Table 33. Russia Clinical Trials Market by Phase, 2021-2031, $ mn 123
Table 34. Russia Clinical Trials Market by Design, 2021-2031, $ mn 123
Table 35. Russia Clinical Trials Market by Indication, 2021-2031, $ mn 123
Table 36. Clinical Trials Market in Rest of Europe by Country, 2021-2031, $ mn 125
Table 37. Percentage of Registered Studies by Location (as of February 24, 2022) 128
Table 38. Percentage of Recruiting Studies by Location (as of February 24, 2022) 128
Table 39. Accell Clinical Research LLC: Company Snapshot 131
Table 40. Accell Clinical Research LLC: Business Segmentation 132
Table 41. Accell Clinical Research LLC: Product Portfolio 132
Table 42. Charles River Laboratories: Company Snapshot 133
Table 43. Charles River Laboratories: Product Portfolio 134
Table 44. Charles River Laboratories: Breakdown of Revenue by Division 134
Table 45. Charles River Laboratories: Breakdown of Revenue by Region 135
Table 46. ClinDatrix Inc: Company Snapshot 136
Table 47. Clinipace: Company Snapshot 137
Table 48. Clinipace: Product Portfolio 138
Table 49. Eli Lilly and Company: Company Snapshot 139
Table 50. Eli Lilly and Company: Pharmaceutical Brands 140
Table 51. Eli Lilly and Company: Clinical Trial Service 140
Table 52. Eli Lilly and Company: Breakdown of Revenue by Therapeutic Area 140
Table 53. Eli Lilly and Company: Breakdown of Revenue by Region 141
Table 54. F. Hoffmann-La Roche: Company Snapshot 142
Table 55. F. Hoffmann-La Roche: Clinical Trial Service 142
Table 56. F. Hoffmann-La Roche: Business Segmentation 143
Table 57. F. Hoffmann-La Roche: Revenue by Region 143
Table 58. ICON Plc: Company Snapshot 145
Table 59. ICON Plc: Business Segmentation 145
Table 60. ICON Plc: Product Portfolio 146
Table 61. ICON Plc: Revenue by Region, 2020, % 146
Table 62. IQVIA Holdings Inc.: Company Snapshot 148
Table 63. IQVIA Holdings Inc.: Business Segmentation 149
Table 64. IQVIA Holdings Inc.: Revenue by Region, 2020, % 149
Table 65. IQVIA Holdings Inc.: Product Portfolio 150
Table 66. Covance Inc.: Company Snapshot 152
Table 67. Covance Inc.: Product Portfolio 153
Table 68. Covance Inc.: Revenue by Region, 2020, % 154
Table 69. Novo Nordisk: Company Snapshot 156
Table 70. Novo Nordisk: Product Portfolio 157
Table 71. Novo Nordisk: Breakdown of Revenue by Business Segment 158
Table 72. Novo Nordisk: Breakdown of Revenue by Region 158
Table 73. PAREXEL International Corporation: Company Snapshot 159
Table 74. PAREXEL International Corporation: Business Segmentation 160
Table 75. PAREXEL International Corporation: Revenue by Region, 2018, % 160
Table 76. PAREXEL International Corporation: Product Portfolio 161
Table 77. Pfizer Inc.: Company Snapshot 163
Table 78. Pfizer Inc.: Business Segmentation 164
Table 79. Pfizer Inc.: Breakdown of Revenue by Product Category 164
Table 80. Pfizer Inc.: Breakdown of Revenue by Region 165
Table 81. Pfizer Inc.: Product Portfolio 165
Table 82. Pfizer Inc.: Revenue, 2018-2020, $ bn 166
Table 83. Pharmaceutical Product Development LLC (PPD): Company Snapshot 168
Table 84. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Division 169
Table 85. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Region 169
Table 86. Phlexglobal: Company Snapshot 171
Table 87. PRA Health Sciences Inc.: Company Snapshot 173
Table 88. PRA Health Sciences Inc.: Business Segmentation 174
Table 89. PRA Health Sciences Inc.: Revenue by Region, 2018, % 174
Table 90. Sanofi: Company Snapshot 175
Table 91. Sanofi: Business Segmentation 176
Table 92. Sanofi: Breakdown of Revenue by Region 176
Table 93. SGS SA (SGS Life Sciences): Company Snapshot 178
Table 94. SGS SA (SGS Life Sciences): Business Segmentation 179
Table 95. SGS SA (SGS Life Sciences): Revenue by Region, 2018, % 179
Table 96. Syneos Health Inc.: Company Snapshot 181
Table 97. Syneos Health Inc.: Business Segmentation 182
Table 98. Syneos Health Inc.: Revenue by Region, 2020, % 182
Table 99. WuXi AppTec Inc.: Company Snapshot 184

 

 

List of Figures:

Figure 1. Research Method Flow Chart 14
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 17
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2031 19
Figure 4. Europe Clinical Trials Market, 2021-2031, $ mn 22
Figure 5. Impact of COVID-19 on Business 27
Figure 6. Primary Drivers and Impact Factors of Europe Clinical Trials Market 33
Figure 7. Percentage of Trial Participants by Country, 2015-2019 36
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million 37
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 38
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 38
Figure 11. Primary Restraints and Impact Factors of Europe Clinical Trials Market 40
Figure 12. Investment Opportunity Analysis 44
Figure 13. Porter’s Fiver Forces Analysis of Europe Clinical Trials Market 47
Figure 14. Breakdown of Europe Clinical Trials Market by Product Category, 2021-2031, % of Revenue 52
Figure 15. Europe Addressable Market Cap in 2023-2031 by Product Category, Value ($ mn) and Share (%) 52
Figure 16. Europe Clinical Trials Market by Product Category: Trials of Drugs, 2021-2031, $ mn 53
Figure 17. Europe Clinical Trials Market by Trials of Drugs: Small Molecule Drugs, 2021-2031, $ mn 54
Figure 18. Europe Clinical Trials Market by Trials of Drugs: Vaccines, 2021-2031, $ mn 55
Figure 19. Europe Clinical Trials Market by Trials of Drugs: Cell & Gene Therapy, 2021-2031, $ mn 56
Figure 20. Europe Clinical Trials Market by Trials of Drugs: Other Drugs, 2021-2031, $ mn 57
Figure 21. Europe Clinical Trials Market by Product Category: Trials of Devices, 2021-2031, $ mn 58
Figure 22. Europe Clinical Trials Market by Product Category: Trials of Procedures, 2021-2031, $ mn 59
Figure 23. Breakdown of Europe Clinical Trials Market by Phase, 2021-2031, % of Sales Revenue 61
Figure 24. Europe Addressable Market Cap in 2023-2031 by Phase, Value ($ mn) and Share (%) 61
Figure 25. Europe Clinical Trials Market by Phase: Phase I, 2021-2031, $ mn 62
Figure 26. Europe Clinical Trials Market by Phase: Phase II, 2021-2031, $ mn 63
Figure 27. Europe Clinical Trials Market by Phase: Phase III, 2021-2031, $ mn 64
Figure 28. Europe Clinical Trials Market by Phase: Phase IV, 2021-2031, $ mn 65
Figure 29. Breakdown of Europe Clinical Trials Market by Design, 2021-2031, % of Sales Revenue 67
Figure 30. Europe Addressable Market Cap in 2023-2031 by Design, Value ($ mn) and Share (%) 67
Figure 31. Europe Clinical Trials Market by Design: Interventional Studies, 2021-2031, $ mn 68
Figure 32. Europe Clinical Trials Market by Interventional Studies: Randomized Control Trial, 2021-2031, $ mn 70
Figure 33. Europe Clinical Trials Market by Interventional Studies: Adaptive Clinical Trial, 2021-2031, $ mn 71
Figure 34. Europe Clinical Trials Market by Interventional Studies: Non-randomized Control Trial, 2021-2031, $ mn 72
Figure 35. Europe Clinical Trials Market by Design: Observational Studies, 2021-2031, $ mn 73
Figure 36. Europe Clinical Trials Market by Observational Studies: Cohort Study, 2021-2031, $ mn 75
Figure 37. Europe Clinical Trials Market by Observational Studies: Case Control Study, 2021-2031, $ mn 76
Figure 38. Europe Clinical Trials Market by Observational Studies: Cross Sectional Study, 2021-2031, $ mn 77
Figure 39. Europe Clinical Trials Market by Observational Studies: Ecological Study, 2021-2031, $ mn 78
Figure 40. Europe Clinical Trials Market by Design: Expanded Access Trials, 2021-2031, $ mn 79
Figure 41. Breakdown of Europe Clinical Trials Market by Service Type, 2021-2031, % of Revenue 81
Figure 42. Europe Addressable Market Cap in 2023-2031 by Service Type, Value ($ mn) and Share (%) 81
Figure 43. Europe Clinical Trials Market by Service Type: Protocol Designing, 2021-2031, $ mn 82
Figure 44. Europe Clinical Trials Market by Service Type: Site Identification, 2021-2031, $ mn 83
Figure 45. Europe Clinical Trials Market by Service Type: Patient Recruitment, 2021-2031, $ mn 84
Figure 46. Europe Clinical Trials Market by Service Type: Laboratory Services, 2021-2031, $ mn 85
Figure 47. Europe Clinical Trials Market by Service Type: Bioanalytical Testing Services, 2021-2031, $ mn 86
Figure 48. Europe Clinical Trials Market by Service Type: Clinical Trial Data Management Services, 2021-2031, $ mn 87
Figure 49. Europe Clinical Trials Market by Service Type: Clinical Trial Supply & Logistic Services, 2021-2031, $ mn 88
Figure 50. Europe Clinical Trials Market by Service Type: Decentralized Clinical Trial Services, 2021-2031, $ mn 89
Figure 51. Europe Clinical Trials Market by Service Type: Medical Device Testing Services, 2021-2031, $ mn 90
Figure 52. Europe Clinical Trials Market by Service Type: Other Clinical Trial Services, 2021-2031, $ mn 91
Figure 53. Breakdown of Europe Clinical Trials Market by Indication, 2021-2031, % of Revenue 93
Figure 54. Europe Addressable Market Cap in 2023-2031 by Indication, Value ($ mn) and Share (%) 93
Figure 55. Europe Clinical Trials Market by Indication: Oncology, 2021-2031, $ mn 94
Figure 56. Europe Clinical Trials Market by Indication: Infectious Diseases, 2021-2031, $ mn 95
Figure 57. Europe Clinical Trials Market by Indication: Cardiology, 2021-2031, $ mn 96
Figure 58. Europe Clinical Trials Market by Indication: Obesity, 2021-2031, $ mn 97
Figure 59. Europe Clinical Trials Market by Indication: Diabetes, 2021-2031, $ mn 98
Figure 60. Europe Clinical Trials Market by Indication: Neurology, 2021-2031, $ mn 99
Figure 61. Europe Clinical Trials Market by Indication: Immunology, 2021-2031, $ mn 100
Figure 62. Europe Clinical Trials Market by Indication: Pain Management, 2021-2031, $ mn 101
Figure 63. Europe Clinical Trials Market by Indication: Other Indications, 2021-2031, $ mn 102
Figure 64. Breakdown of Europe Clinical Trials Market by End User, 2021-2031, % of Revenue 103
Figure 65. Europe Addressable Market Cap in 2023-2031 by End User, Value ($ mn) and Share (%) 104
Figure 66. Europe Clinical Trials Market by End User: Pharmaceutical and Biotechnological Companies, 2021-2031, $ mn 105
Figure 67. Europe Clinical Trials Market by End User: Clinical Research Organizations, 2021-2031, $ mn 106
Figure 68. Europe Clinical Trials Market by End User: Clinical Testing Laboratories, 2021-2031, $ mn 107
Figure 69. Europe Clinical Trials Market by End User: Other End Users, 2021-2031, $ mn 108
Figure 70. Breakdown of European Clinical Trials Market by Country, 2022 and 2031, % of Revenue 110
Figure 71. Contribution to Europe 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 111
Figure 72. Clinical Trials Market in Germany, 2021-2031, $ mn 112
Figure 73. Clinical Trials Market in U.K., 2021-2031, $ mn 114
Figure 74. Clinical Trials Market in France, 2021-2031, $ mn 116
Figure 75. Clinical Trials Market in Spain, 2021-2031, $ mn 118
Figure 76. Clinical Trials Market in Italy, 2021-2031, $ mn 120
Figure 77. Clinical Trials Market in Russia, 2021-2031, $ mn 122
Figure 78. Clinical Trials Market in Rest of Europe, 2021-2031, $ mn 124
Figure 79. Growth Stage of Europe Clinical Trials Industry over the Forecast Period 126

 

 

Reviews

There are yet no reviews for this product.